ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

Exploring Vaccination in Low-Grade Glioma With the Aim of Preventing High-Grade Transformation

Hideho Okada, MD, PhD
Published Online:2:18 PM, Wed May 17, 2017

Hideho Okada, MD, PhD, director, Brain Tumor Immunotherapy Center, professor of Neurological Surgery, University of California, San Francisco, discusses a study exploring vaccination in low-grade glioma aiming at prevention of high-grade transformation. 
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.